These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The immunosuppressive effect of Cytembena in rheumatoid arthritis (author's transl)]. Truhlár P; Matl I Cas Lek Cesk; 1975 Jan; 114(5):150-2. PubMed ID: 1120331 [No Abstract] [Full Text] [Related]
4. [Actual results of the rheumatoid polyarthritis therapy with immuno-suppressive drugs: d-penicillamine and cytostatics (author's transl)]. Barnes CG Schweiz Rundsch Med Prax; 1977 Nov; 66(44):1412-20. PubMed ID: 928306 [No Abstract] [Full Text] [Related]
5. [New Czechoslovak cytostatic preparation Cytembena in the treatment of rheumatoid arthritis (author's transl)]. Truhlár P; Machácek P; Smahel O Cas Lek Cesk; 1973 Nov; 112(45):1401-2. PubMed ID: 4800526 [No Abstract] [Full Text] [Related]
6. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)]. Warnatz H; Scheiffarth F; Gutmann W Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648 [TBL] [Abstract][Full Text] [Related]
7. Immunological defence mechanisms and immuno-suppressive therapy in rheumatoid arthritis. Denman AM Adv Clin Pharmacol; 1974; 6():105-13. PubMed ID: 4619740 [No Abstract] [Full Text] [Related]
8. [Prophylaxis and therapeutics of iatrogenic consequences, produced by treatment of rheumatoid arthritis (author's transl)]. Vanslype J; Tritsmans E; Verstraete J Acta Rhumatol Belg; 1978; 2(1-2):22-33. PubMed ID: 751468 [No Abstract] [Full Text] [Related]
9. Immunosuppressive therapy in rheumatoid arthritis. Rainer F Acta Med Austriaca; 1988; 15(5):137-40. PubMed ID: 3064524 [TBL] [Abstract][Full Text] [Related]
10. [Experience with immunosuppressive therapy in rheumatoid arthritis?]. Mathies H Dtsch Med Wochenschr; 1968 Jan; 93(2):95. PubMed ID: 5634965 [No Abstract] [Full Text] [Related]
12. Immunosuppressive agents in the treatment of rheumatoid arthritis. Kimler WD J Med Soc N J; 1971 Sep; 68(9):721-2. PubMed ID: 5285954 [No Abstract] [Full Text] [Related]
13. [Indications and limitations of immunosuppressive treatment in rheumatoid arthritis]. Chlud K Reumatizam; 1972; 19(1):1-8. PubMed ID: 5023361 [No Abstract] [Full Text] [Related]
14. [Immunosuppressive drugs for rheumatoid arthritis]. Azuma T Ryumachi; 1987 Oct; 27(5):392-8. PubMed ID: 3454495 [No Abstract] [Full Text] [Related]
15. [Immunodepressive agents in therapy of rheumatoid arthritis. II. Changes in the titers of immunoglobulins and rheumatoid factor]. Carrozzo M; Loizzi P; Arbore S; Latorre F; Pipitone V Folia Allergol (Roma); 1971; 18(2):121-6. PubMed ID: 5111809 [No Abstract] [Full Text] [Related]
16. [Symposium II. 4-1. Long-term immunosuppressive therapy for rheumatoid arthritis]. Kobayashi I; Imura S Ryumachi; 1973 Jan; 13(1):48-9. PubMed ID: 4726792 [No Abstract] [Full Text] [Related]
17. [Immunosuppressive agents in rheumatoid polyarthritis. Introduction]. de Sèze S; Kahn MF Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):737-9. PubMed ID: 5152705 [No Abstract] [Full Text] [Related]
18. [Immunosuppressive drugs in systemic lupus erythematosus and rheumatoid arthritis]. Talpaz M Harefuah; 1980; 98(10):468-71. PubMed ID: 7450579 [No Abstract] [Full Text] [Related]
19. [Treatment of rheumatoid arthritis with immunosuppressive agents]. Inzoli MR; Almici C Minerva Med; 1973 Aug; 64(57):2987-91. PubMed ID: 4742637 [No Abstract] [Full Text] [Related]
20. [Symposium II. Immunosuppressive therapy in rheumatoid arthritis. 3. Pathologic effects of immunosuppressive agents and their adverse anti-inflammatory effects]. Kyogoku M; Watanabe S; Sagino H; Obu R; Shimomura R Ryumachi; 1973 Jan; 13(1):38-47. PubMed ID: 4726791 [No Abstract] [Full Text] [Related] [Next] [New Search]